Home/Pipeline/miSignal Urinary Cancer Test

miSignal Urinary Cancer Test

Cancer Risk Screening

CommercialAvailable in Japan

Key Facts

Indication
Cancer Risk Screening
Phase
Commercial
Status
Available in Japan
Company

About Craif

Craif develops AI-powered, non-invasive cancer detection tests using urine and saliva biomarkers to shift healthcare from treatment to prevention.

View full company profile

Therapeutic Areas